Kollars, Thomas M. – Trademark Portfolio
Entity Type: 01
Kollars, Thomas M. has 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include PROVECTOR. The portfolio includes 1 registered trademark. Filings span 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 21 (Housewares). This trademark owner is based in Statesboro, GA.
260 Langston Chapel Rd
Statesboro, GA 30458
Showing of trademarks Trademarks
Trademark Classifications
Kollars, Thomas M.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Kollars, Thomas M. have?
Kollars, Thomas M. has 13 U.S. trademarks filed with the USPTO. Of these, 1 registered, 12 abandoned.
What trademark classes does Kollars, Thomas M. file in?
Kollars, Thomas M. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 21 (Housewares), Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 45 (Legal & Security Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Kollars, Thomas M.'s most well-known trademarks?
Kollars, Thomas M.'s registered trademark portfolio includes well-known marks such as PROVECTOR. These are among 1 currently registered trademark in the portfolio.
What is Kollars, Thomas M.'s trademark registration success rate?
Kollars, Thomas M. has a 8% trademark registration rate, with 1 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.